Skip to main content
. 2023 Jun 2;13(7):1477–1487. doi: 10.1007/s13555-023-00938-8

Table 3.

Summary of 30 percent decrease of VAS value (FAS and PPS)

FAS PPS
Placebo group (n = 120) Treatment group (n = 120) Placebo group (n = 110) Treatment group (n = 114)
30 percent decrease of VAS value Not achieved (N, %) 101 (84.17%) 79 (65.83%) 93 (84.55%) 73 (64.04%)
Achieved (N, %) 19 (15.83%) 41 (34.17%) 17 (15.45%) 41 (35.96%)
χ2 11.10 12.76
p 0.0009 0.0004